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Abstract The market for cosmetic surgery tourism is growing with an increase in
people travelling abroad for cosmetic surgery. While the reasons for seeking cos-
metic surgery abroad may vary the most common reason is financial, but does
cheaper surgery abroad carry greater risks? We explore the risks of poorly regulated
cosmetic surgery to society generally before discussing how harm might be mag-
nified in the context of cosmetic tourism, where the demand for cheaper surgery
drives the market and makes surgery accessible for increasing numbers of people.
This contributes to the normalisation of surgical enhancement, creating unhealthy
cultural pressure to undergo invasive and risky procedures in the name of beauty. In
addressing the harms of poorly regulated surgery, a number of organisations purport
to provide a register of safe and ethical plastic surgeons, yet this arguably achieves
little and in the absence of improved regulation the risks are likely to grow as the
global market expands to meet demand. While the evidence suggests that global
regulation is needed, the paper concludes that since a global regulatory response is
unlikely, more robust domestic regulation may be the best approach. While
domestic regulation may increase the drive towards foreign providers it may also
have a symbolic effect which will reduce this drive by making people more aware of
the dangers of surgery, both to society and individual physical wellbeing.
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Introduction
Travelling abroad for medical reasons is not a new phenomenon. Victorian
travellers who travelled to ‘take the waters’ or to breathe fresh sea or mountain air
for health purposes helped to lay the foundations of modern tourism [25]. More
recently, however, a new type of medical tourist has emerged. Cosmetic surgery
tourism is a fast growing market and in a global society the reasons for seeking
cosmetic surgery abroad may vary significantly. Elite consumers may seek the
services of the very best cosmetic surgeons in the world, while those seeking more
extreme or even risky procedures may simply be unable to get what they want in the
UK. The most common reason for travelling abroad for cosmetic surgery rather than
remaining in one’s home country to access domestic services, however, is financial.
Cosmetic surgery can be considerably less expensive outside the UK, with a recent
report suggesting that popular procedures such as ‘nose jobs’ (rhinoplasty) and
breast augmentation may be approximately £2000 cheaper in the Czech Republic
and Poland than in the UK.1 Consequently, the increasing appetite for affordable
cosmetic surgery has led to a growth in such surgical holidays. And although the
services that this new breed of traveller is seeking are indeed medical—hopefully
involving qualified surgeons working within private hospitals—the consequences of
travelling abroad for cosmetic surgery, within a highly commercial and poorly
regulated industry, may be far from medically beneficial.
In this paper we explore some of the concerns over the rapidly expanding global
market in cosmetic surgery before considering the challenges of attempting to
regulate the cosmetic surgery market. Data available on cosmetic surgery is patchy;
there are small-scale sociological studies, surveys conducted by certain interested
parties including professional organisations of plastic surgeons and medical defence
organisations who represent surgeons in legal proceedings, and there is some data
kept by the NHS. Such lack of evidence means that we do not have truly accurate
data on the incidence of procedures in the UK and elsewhere or the resulting harm.
Yet there is a lot we can glean from the data that does exist, although in using the
data in this paper we do not claim our conclusions are representative.
We begin by briefly reviewing the evidence and recent developments pertaining
to cosmetic surgery in the UK, considering what is driving the increase in such
surgery and what cultural and physical harms are resulting, as well as how the law
might respond. We then situate the domestic evidence within the global
phenomenon of cosmetic surgery. We assess the evidence and apparent risks of
cosmetic surgery tourism and the implications for the UK and the NHS in particular.
We ask whether such foreign surgery should necessarily, and always, be regarded as
more dangerous or whether the domestic market is raising concerns in order to
protect itself. Either way we argue that the global trends are harmful but while a
domestic response is crucial, its power to reduce harm is restricted by the drive for
cheaper surgery in certain foreign countries.
1 For example, breast augmentation costs approximately £1972 in Poland compared to £3736 in the UK.
See, ‘Cosmetic surgery abroad: Is it worth the risk?’ The Guardian, Matthew Jenkin, 4 August 2014.
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In the context of global dominant beauty norms and the cultural and individual
physical harms that they bring, we conclude by asking what the role of the law
should be in this context. Is a global regulatory response possible? If the potential
for global regulation is extremely limited we should consider how else to address
the harms at stake and begin by addressing the inadequacy of domestic regulation.
In response to the concern that tighter domestic regulation will encourage cosmetic
tourism we agree with McHale that ‘it is too easy to assume that globalisation
means that resistance in the form of regulation is futile’ [21]. Consequently we
argue that a domestic regulatory response that seeks to make cosmetic surgery
provision subject to increased governance is necessary to combat the dual harms
(cultural and physical) we identify. Firstly, tighter regulation would make
commercial provision safer for the consumer. Secondly, it would send a clear
message about the potential dangers of cosmetic surgery in order to influence
societal perceptions and resist the increasing normalisation of surgery as beauty
treatment.
The Growth and Normalisation of Cosmetic Surgery Within the UK:
Difference and Sameness
Plastic surgery is surgery undertaken for the purposes of altering the appearance of a
patient. There are two subfields within the broader medical practice of plastic
surgery. Reconstructive surgery is defined as work that seeks to ‘repair,
catastrophic, congenital, or cancer-damage deformities and is seen as restorative
of a somehow damaged appearance, whereas cosmetic surgery is defined as ‘entirely
elective’ work that is seen as purely as enhancement of appearance [3]. And while
all surgery carries risks, the risks of cosmetics surgery should be more carefully
weighed because they cannot be justified on health grounds but rather, the serious
risks are undertaken for purely aesthetic reasons. This aesthetic rather than
therapeutic purpose, as we have argued elsewhere [12], changes the nature of the
risk/benefit analysis and, compared to medically necessary surgery, the risk/benefit
analysis of cosmetic surgery should necessitate a more precautionary approach.
Over the past few decades, societal attitudes to cosmetic surgery have evolved
quite dramatically. Undergoing surgery as a beauty enhancing treatment has become
a lifestyle choice for increasing numbers of people, with a significant increase in
people electing to undergo such procedures. According to the British Association of
Aesthetic Plastic Surgeons (BAAPS), 50,122 cosmetic procedures were performed
in 2013, a rise of 17% from 2012 [5]. The cosmetic surgery industry was worth
£750 m in the UK in 2005, £2.3bn in 2010, and is forecast to reach £3.6bn by 2015
[10]. As Sir Bruce Keogh’s review of the industry recently reported, rising demand
for cosmetic enhancement has been driven by a number of socio-economic and
technological factors, leading to the normalisation of serious and potentially
harmful cosmetic interventions [17]. Keogh’s report and other evidence shows that
while surgery was once undertaken discreetly, now many more people will admit to
it and even celebrate it. The media, social media, celebrity endorsement and
advertising have been central to this normalisation [21].
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Looking at gender issues within this phenomenon, we can see that while men are
opting for surgery in greater numbers than ever before, it is still women who
predominantly undergo such treatments [17]. The early feminist position was that
women who have cosmetic surgery are victims of a patriarchal culture and beauty
industry that pressurises them into making themselves more sexually desirable to
men. Within this initial feminist response, women undergoing surgery are viewed as
passive victims of a patriarchal system who are capitulating to their own sexual
objectification. Subsequently this view was challenged by other feminists who
emphasised questions of choice, autonomy and self-determination. Most famous in
this respect is Kathy Davis’s work, which portrays women as active agents,
carefully negotiating and controlling their surgeries rather than being mere puppets
of patriarchy. However, this account has been critiqued for overemphasising
women’s agency. Bordo, for example, states that Davis presents the self as an
‘authentic and personal reference point untouched by external values and demands
or relations with others [4]. The third position that has evolved, and which accords
more with our position, regards the motivation for cosmetic surgery as neither fully
internal nor external but rather an intersubjective and embodied process that takes
place in a consumerist environment [22].
Placing aesthetic non therapeutic surgery within an intersubjective and
consumerist context shifts the focus away from the disembodied individual
cosmetic surgery patient that has dominated much previous research (which
portrays her as either the victim of patriarchy or free autonomous agent), and allows
us to take into account agency and choice within constrained cultural context.
Bodies are active and reflexive but also heavily influenced by other bodies and
gendered and racialised norms [26]. In this position, cosmetic surgery is approached
as ‘a purchase, characterised by the rhetorics of fashion, consumption and self-
presentation rather than medical or psychological necessity’ [22]. Here then for us
‘consumption of cosmetic surgery is a strategic act on the part of individuals who
are rational and intelligent but who reside in a structural context where class, gender
and race determine action’ [22]. Latham’s work has also been informative here [19].
Following her review of the feminist literature Latham advocated for a ‘third way’,
which promotes a relational approach to autonomy and which seeks to address the
conflicting feminist concerns through more precautionary yet pragmatic regulation.
Also significant is the fact that when we talk about consumers of surgery (both
nationally and globally), we are talking about aged, classed and raced women.
While surgery has become normalised, and global norms can be discerned, women
are differently placed in relation to this normalisation in the UK and globally
according to the cultural and social environment in which they reside. For example,
in relation to social class, as Jacqueline Sanchez Taylor has recently noted ‘we are
not all the same kind of makeover citizens, nor do we all experience the same
pressure to conform to the same patriarchal ideals of feminine beauty.’ Some
women, middle class academics for example, can (usually) do their gender without
undergoing invasive procedures, they will not be dishonoured by their lack of
attention to the kind of beauty and fashion regimes which are important to some
other women and, in fact the reverse is often true, within an environment where low
key performances of gender are typically more highly valued and respected [24].
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In an ESRC study ‘Sun, Sea, Sand and Silicone’ women from different countries
who were undergoing foreign cosmetic surgery were tracked [14]. Cultural
differences in procedures the women wanted undertaken and why they were
undertaking them were stark. For example, 44% of the British sample and 66% of
the Australian sample were travelling abroad for breast augmentations. This
procedure was absent for the sample of Chinese women who were travelling to
South Korea for surgery, for whom eyelid, jawbone and nose jobs made up 88% of
the total. The UK women were defined as mostly working class women, while the
Chinese patients were mostly middle class women who sought better quality surgery
than that which is available in China.
Sanchez Taylor has observed that:
[W]e may all live as engendered beings in a patriarchal society(ies), and may
all metaphorically be cosmetic surgery recipients, we also have different class,
age, sexual and racialized identities (as well as being differentiated along the
lines of able-bodiness/disability) and so stand in different relations to outward
displays of gender and are positioned differently in relation to contemporary
discourses and practices of cosmetic surgery [24].
Recognising such difference is thus essential when we look at cosmetic surgery
because not all women stand in the same relationship to beauty norms and the
pressures to have surgery. While certain global beauty norms may be evident, such
as the desire to look young, there are still key differences. Despite such differences,
however, it is true to say that generally women share many of the pressures and for
women who do turn to cosmetic surgery, similar risks may be apparent. Indeed,
when we consider the potential risks and real harm that such surgery involves, both
physically and arguably also culturally, we can see that many of the concerns are
universal.
Harm and Risk in UK Cosmetic Surgery
There are firstly the risks of what Jean McHale has described as ‘normalising
perfection’ as well as pathologising imperfection [21]. Cosmetic surgery reinforces
and heightens concern with body image and culturally prescribed standards of
beauty, contributing to a youth culture that distains aging and the elderly and
upholds culturally specific standards of beauty. It also promotes inequality between
those who have the resources to purchase an enhanced appearance and those who
don’t. As McHale has asked, will the ‘cosmetically unenhanced become an
effectively unemployable underclass?’ [21]. While women are differently placed in
relation to having to conform to standards of beauty and surgical enhancement, none
are untouched by being placed in relation to these standards and even those women
who do not feel beholden to explicit gender performances (or even surgery for
economic or cultural capital) may be discredited in wider society for not doing so.
The physical risks of cosmetic surgery have most starkly and recently been
illuminated by the PIP (Poly Implant Prothese) breast implant scandal, which
resulted in global outrage after the French implant company, PIP, were found to
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have used industrial grade silicon in their product.2 More generally, data on harm in
cosmetic procedures is scarce but some information is available from medical
negligence claims. According to a major analysis of cosmetic surgery done by the
Medical Defence Union (MDU), growing numbers of patients are suing cosmetic
surgeons over mistakes during operations designed to improve their appearance.3
Data from this analysis shows that negligence claims concerning breast surgery,
facelifts, eyelid operations, nose reductions, and weight-loss procedures account for
80% of claims stemming from cosmetic surgery and damages of more than
£500,000 were paid out over a five year period. The MDU state that cosmetic
surgery negligence claims are successful in 45% of cases, compared with 30% of
medical negligence claims in general. This success rate would suggest that when
harm occurs from cosmetic surgery, the presence of negligent behaviour is more
often clearer and easier to prove than when harm occurs from medically necessary
surgery. The reasons for this are unknown, however, we suggest that this might be at
least partly because the surgery is not carried out for therapeutic reasons and so the
resulting harm, to a victim who was (presumably) previously in good health, is an
obvious sign that mistakes have been made. Additionally, the lack of regulation has
meant that within the private market for cosmetic surgery, too often poorly qualified
surgeons are undertaking procedures for which there has been an inadequate consent
process coupled with inadequate consideration of the patient’s health and well
being, which further heightens the usual risks associated with invasive surgery [17].
For this reason, as we have argued elsewhere [12], the unquestioning assumption
that non-therapeutic cosmetic surgery is justified under the medical exception to the
(English) criminal law as ‘proper medical treatment’, has led to a complacent
approach to regulation that requires urgent attention.
In response to the Keogh Review, there have been some developments but not
enough to fully protect the cosmetic surgery consumer. Consequently, the president
of BAAPS, Rajiv Grover, has commented that: ‘It’s business as usual in the Wild
West and the message from the government is clear: roll up and feel free to have a
stab’ [18]. Some improvements, however, have been made. The Royal College of
surgeons in October 2016 launched new guidance for patients on cosmetic surgery
to protect them from ‘aggressive marketing’ and ‘ruthless’ sales tactics and they
expected to create a register of certified surgeons who are appropriately qualified to
provide particular procedures.4 The General Medical Council also issued new
guidance which sets out the standards they expect from doctors who provide
cosmetic interventions, including stipulations to market their services responsibly,
seek a patient’s consent themselves rather than delegate this to somebody else and
consider patients’ vulnerabilities and psychological needs when making decisions
2 See ‘PIP breast implant scandal: compensation ruling upheld’ The BBC, 21 January 2014, available at
http://www.bbc.co.uk/news/world-europe-25831237 Accessed 10 August 2015.
3 According to the Medical Defence Union, growing numbers of patients are suing plastic surgeons over
mistakes during operations designed to improve their appearance. See MDU Journal, Volume 27, Issue 2
November 2011. See also http://www.theguardian.com/society/2012/jan/08/patients-sue-plastic-
surgeons-faulty. Accessed 22 October 2014.
4 See the Royal College of Surgeons webpages: http://www.rcseng.ac.uk/surgeons/surgical-standards/
working-practices/csic/main-areas-of-work.
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with them about treatment options.5 While this presumably will not do anything to
prevent poorly qualified doctors from offering their services as a cosmetic surgeon,
it will, at least, allow prospective consumers of cosmetic surgery services to
ascertain whether the surgeon in question is appropriately qualified. Hopefully
therefore, we may anticipate a marginally better regulated collection of cosmetic
surgery providers in the UK. Yet in spite of the expected improvement, we question
whether these small measures go far enough. Moreover, even if safety is eventually
improved through the creation of the cosmetic surgeons register, this would do little
to address the cultural harms that cosmetic surgery perpetuates, particularly for
women.
Reforming the Regulation of Cosmetic Surgery in the UK?
Currently cosmetic surgery in the UK is regulated in the exactly same way as
medically necessary surgery. As we have mentioned above, cosmetic surgery is
defined as acceptable and legitimate medical practice (‘proper medical treatment’),
alongside medically necessary or beneficial surgery. As a matter of public policy,
the criminal law prohibits consensual harmful activities unless they can be justified
because they are medically necessary, or carried out in pursuit of legitimate sporting
activity.6 The only time that a doctor might fall under the scrutiny of the criminal
law for harming a patient will be if that patient dies. If death occurs as a result of a
medical blunder—and assuming the doctor did not intentionally kill the patient, for
that would be murder—a charge of gross negligence manslaughter could follow.
Essentially therefore, the reckless cosmetic surgeon who harms (but does not kill) a
patient through performing ill-considered, inadvisable and negligent surgery will
not be troubled by the criminal law. Where surgery is concerned, provided it is in
the best interests of the patient and is carried out by a qualified healthcare
professional, there is no question that it falls within the medical exception to the
criminal law and is thus lawful. But having considered the risks we might ask when,
if ever, is non therapeutic and potentially harmful surgery in a person’s best
interests?
We have argued elsewhere that when patients suffer at the hands of cosmetic
surgeons, who, driven by commercial profit, recklessly undertake risky and non-
therapeutic surgery, the usual public policy justification for the medical exception is
absent [12]. For this reason we have suggested that there should be a more
significant role for the criminal law, through the use of the Offences Against the
Person Act 1961, when serious harm is inflicted. Detailed consideration of the
criminal law is beyond the scope of this article, other than to say that the main
obstacle to a greater role for the criminal law is the medical exception, which
surgeons rely upon to legitimise what might otherwise be harmful criminal conduct.
The medical exception rests on assumptions that surgery is performed in the best
5 See General Medical Council Guidance on cosmetic interventions http://www.gmc-uk.org/guidance/
ethical_guidance/28687.asp.
6 See for example R v Brown [1993] 2 All ER 75.
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interests of the patient because it is therapeutic, or it is in the interests of another (for
example, when donating a kidney).7 The difficulty here is that there is sometimes a
fine line between plastic surgery for therapeutic reasons and non-therapeutic
cosmetic surgery. For example, consider breast augmentation surgery for recon-
struction after a mastectomy due to cancer, which is evidently therapeutic,
compared with breast enhancement to treat psychological issues with self-image.
The latter may also be therapeutic in a sense, but it does nothing to treat the possible
psychological causes for the lack of self-worth and it harms physical health via the
surgery. While sometimes no clear line can be drawn, in our previous paper we
define all non-therapeutic cosmetic surgery along the same lines as the NHS [12].
We have also suggested that even when the surgery goes well, the professional
ethics of the surgeon in normalising such invasive interventions for cosmetic
purposes have a harmful societal effect and so, for this reason also, cosmetic surgery
should not be included within the definition of ‘proper medical treatment’ as a
means for justifying it. Instead, much tighter regulation and sufficiently informed
consent for all non-therapeutic cosmetic surgery should be required in order to
legitimise its performance rather than by recourse to the medical exception. This
could look like the model in France where, following the enactment of the Kouchner
law 2002, regulation is much stricter, consent procedures are far more detailed, and
additional safeguards regulating advertising and requiring a ‘cooling-off’ period, to
allow the consumer to reflect on the decision, have been brought in [9, 20].
Moreover, when things do go wrong in French cosmetic surgery, as generally in
French medicine, there is a much more significant role for the criminal law [16].
Latham was hopeful that following the Keogh Review, the British government
might look to the French approach to inform legal change in the UK but
unfortunately this now seems unlikely [20]. While the GMC have recently (April
2016) issued ethical ‘Guidance for doctors who offer cosmetic interventions’, which
is a welcome development, in the absence of substantive legal reform we might
expect little if any improvement within commercial provision.
For others, even improved regulation might not go far enough. Dennis Baker has
argued, like us, that cosmetic surgery is harmful in a direct sense because it causes
physical harm and in an indirect sense because it reinforces artificial celebrity or
racist appearances as the preferred social norm [1]. For Baker better regulation
would not significantly reduce either of those harms, and so he has argued that all
significantly invasive cosmetic surgery should be regarded as a criminal offence and
thus prohibited because it is inherently harmful. Baker also argues that consent
cannot be used to justify such harms, commenting that: ‘The medical profession has
hidden the criminal harm in unnecessary cosmetic surgery by dressing it up as
genuine medicine’ [1]. For Baker, it should be criminalised because it involves
wrongful harm. While we agree that the current approach is highly problematic, we
do not agree that competent adults should be prevented from seeking lawful
cosmetic surgery within the UK. A ban would simply drive such surgery
underground and overseas where the dangers may be greater. Furthermore, as we
7 For a discussion see P Lewis,(2012) ‘The Medical Exception’, Current Legal Problems, 65: 355
Griffiths and Mullock, above n5.
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have discussed above, although we share concerns that some women seeking
cosmetic surgery may be viewed as victims of patriarchy, an informed choice to
surgically enhance oneself may be viewed as a rational and positive life choice
within the context of that individual’s circumstances.
Like Baker, McHale has focused on the law as it applies to the choices that
children can take in respect of their bodies and cosmetic surgery. McHale asks
whether regulation and/or outright criminalisation of certain cosmetic procedures
concerning children and adolescents should now be considered and she pinpoints
Queensland in Australia as an interesting and instructive example where such
sanctions apply. However, as McHale notes, a key weakness within arguments
concerning tighter regulation and criminalisation is that domestic law is constrained
by what is now a global market in healthcare, which has become particularly
significant in relation to cosmetic surgery. McHale asks; ‘would the adolescent and
parent denied surgery in the UK simply hop on Eurostar or EasyJet and receive
treatment elsewhere?’ [21]. Clearly it is highly likely that this question would be
answered in the affirmative. Thus, in a global cosmetic surgery market, domestic
regulation may be irrelevant to the growing tide of tourists who elect to seek
cosmetic surgery services abroad. Domestic regulation could also drive an increase
in such tourism if surgery becomes too expensive and difficult to access in the UK.
This would evidently be an unwelcome development if it brought with it additional
risks and harms, especially harms that would also be potentially costly to the NHS.
Cosmetic Surgery Tourism: Risks and Harms
In order to consider the regulatory challenges within a global cosmetic surgery
market, it is important to explore the evidence and risks regarding cosmetic surgery
tourism. Such tourism, which might be defined as the movement of patients from
one location to another to undertake aesthetic procedures, is a significant and
growing area of medical tourism [2]. The UK’s annual International Passenger
survey shows that approximately 100,000 UK citizens go abroad each year for
medical treatment, which is projected to rise about 20% per year. Evidence from
other jurisdictions is also illuminating. For example, cosmetic surgery tourists make
up about 85% of Australian medical tourists [2]. In the UK figures are harder to find
but a survey conducted by Treatment Abroad found that, including dental treatment
and obesity surgery (for have cosmetic purposes), cosmetic procedures account for
60–70% of all medical tourism (42% excluding dental and obesity).
With respect to the top destinations for UK tourists for cosmetic surgery, we see
that Poland (40%), then Spain, India, Tunisia, Czech Republic are the most
significant markets.8 Some early studies have presented the surgery tourist as highly
mobile, wealthy elites [8]. Other recent empirical research has in fact found that
these consumers are far from wealthy, most often being lower middle class and
working class women [14]. Confirming this, as mentioned earlier, it has been found
in many studies that cost is the motivating factor influencing decisions to travel
8 See http://www.ssss.leeds.ac.uk/files/2012/11/Preliminary-Findings-Brochure.pdf.
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abroad (with the exception of China where travel was to seek out better quality
surgery).
When a person elects to travel abroad in order to undergo cosmetic surgery, there
are a number of reasons why the usual risks of surgery may be magnified, yet there
is little clear evidence to suggest that cosmetic surgery abroad is necessarily
dangerous. In order to explore the risks, we have identified the main concerns as
follows: a primary concern is that it will often be more difficult to check that the
clinic/hospital in a foreign destination is safe and reputable. In the UK the Care
Quality Commission (CQC) regulates all such surgical providers and while there
may be similar regulatory organisations and mechanisms in some countries this will
vary significantly. Moreover, even where such regulatory agencies exist, the
language barrier may make it difficult to access any relevant information.
Secondly and similarly, checking that a surgeon working outside the UK is
appropriately qualified will often be more challenging. In the UK, although we
await the register of certified cosmetic surgeons, it is at least possible to check a
doctor’s registration with the General Medical Council (GMC). Whether any similar
system operates abroad will depend upon the jurisdiction and, once again, the
customer’s ability to access and understand any relevant information. Linked to
these regulatory issues is the fact that UK providers and surgeons delivering private
cosmetic surgery services must be appropriately insured in case of malpractice so
that the patient may be compensated. Again, there may be a corresponding
requirement in certain other countries but this is by no means universal and if
something does go wrong, pursuing damages within a foreign legal system will
invariably present greater challenges. While insurance may be available to
safeguard such consumers and to enable them to pay legal costs should it be
necessary, this will inflate the cost of seeking surgery abroad and thus some
travellers will not obtain adequate insurance.
A further concern is that patients are usually required to pay for a package deal
prior to travel. Informed consent, if it occurs at all, and the initial consultation may
be superseded by agreeing to the treatment and, crucially, paying for both travel and
treatment. Consequently people who have paid for all or part of the treatment (and
travel) and then travelled abroad to the destination, will naturally feel reluctant to
cancel the planned procedure in the event that the consultation and consent
procedure cause them to reconsider the decision to have surgery. It also raises issues
for after care in the case of complications. If the procedure has been paid for in
advance the package may not include after care or if it does it such after care may
not be accessible if the patient has flown back to their home country.
If the surgery goes well, the very concept of a ‘cosmetic surgery holiday’ carries
dangers because traditional holiday activities, such as lying on a beach, swimming,
sight-seeing and drinking alcohol, are potentially risky following surgery. Finally,
and assuming one flies to the chosen destination, both surgery and air travel
intensify the risk of deep vein thrombosis (DVT) and so flying home shortly after
the surgery should be avoided. The British Association of Plastic, Reconstructive
and Aesthetic Surgeons (BAPRAS) suggest that people should wait five to seven
days after procedures such as breast augmentation or liposuction and seven to ten
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days after facial or abdominal surgery before flying home.9 Considering that most
people elect to have cosmetic surgery abroad to minimise cost, the additional
expense of an extended stay abroad will often compel people to fly home before
they should, thus increasing their chances of suffering DVT. We can therefore see
that the combination of all these additional risks, together with the possible
language barrier and cultural differences within a health care context, make for a
potentially dangerous experience.
But do these concerns translate into actual harm? And if so, is this costly to the
NHS? Regarding cosmetic surgery, Jeevan and Armstrong conducted a survey for
the British Association of Plastic, Reconstructive and Aesthetic Surgeons [15]. 203
out of 325 surgeons responded and of these, 76 (37%) had seen patients in the NHS
with complications arising from overseas cosmetic surgery. In an audit of the pan-
Thames region, 35 out of 65 consultants replied to requests about cosmetic surgery
impacts [15]. Sixty per cent of those replying had seen complications and the
majority of these cases (66%) were emergencies that required inpatient admission.
It is important to note that although the very real risks outlined above present
compelling reasons to urge caution, other evidence of actual harm (especially
beyond that of cosmetic surgery in the UK) paints a different picture. In a study by
Hanefeld et al. [13] the costs and benefits of medical tourism to the NHS presented
more positive figures, with few admissions. Holliday’s research found only 17% of
their participants had complications and of those only 2% were serious [14]. The
research showed that 97% of those participating in the study were happy with the
outcome of the surgery and would recommend their surgeon to a friend [14]. The
high levels of satisfaction are perhaps surprising considering that 17% of this group
experienced complications following the surgery, with 9% requiring further
treatment on their return home [14]. Clues to this response, however, can be
elucidated from other information in the study, which suggests that those questioned
did not undertake the surgery on a whim or with unrealistically optimistic
expectations. Rather, they were ordinary people on modest incomes who took a long
time to reach the decision to access cosmetic surgery abroad. This indicates that
they were conscious of the inherent risks and even where the road to recovery
included complications, provided the ultimate result was satisfactory, the risks were
regarded as worth taking. Yet there are some problems with making too many
positive conclusions from this data. There may also be cases where the NHS does
not cover complications and thus patients do not present in the above studies. In
addition, any levels of satisfaction clearly do not mitigate the costs to the NHS.
Finally even 9% requiring NHS treatment is a significant financial burden to a
stretched health service in terms of patient beds, delayed procedures and public
health risks such as increased antimicrobial resistance stemming from the likely use
of antibiotics with these patients and potential for introducing hospital infections
from their stay in another hospital.
We might also consider how fears regarding services abroad may be inflamed by
the rhetoric of national professional bodies naturally motivated to protect the
national market. Note that the study by Jeevan and Armstrong was conducted for the
9 See http://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad.
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British Association of Plastic, Reconstructive and Aesthetic Surgeons, who arguably
have a vested interest in persuading prospective patients to seek treatment within the
UK. Gimlin has argued that narrative strategies that discredit foreign providers are
employed by organisations seeking to invoke fear in the consumer [11]. Gimlin
provides an account of her own very positive experience of accessing health
services abroad (in Costa Rica), before exploring the way in which cosmetic
surgeons’ professional organisations [11] seek to influence perceptions about
services abroad. Gimlin notes that while the warnings presented on the websites of
these organisations are; ‘framed as ‘educational’ they also portray associations
members’ services as better, safer and more public spirited than those of foreign
practitioners.’ [11] In her study she found British organisations often drew on
constructions of foreign providers as deceitful, unhygienic and primitive.
Notwithstanding the risks involved in seeking such surgery—even if these are
exaggerated by domestic cosmetic surgeons—the other side of the argument is that
the availability of affordable cosmetic surgery abroad enables more widespread
access to services that have long been available to the wealthier few in society.
Thus, the benefits of cosmetic surgery—improved appearance and self-image
leading to the alleviation of psychological anxiety related to the physical body and
greater happiness—are now available to more people. Accordingly, in a society
where previously only the wealthy, or perhaps those sufficiently desperate and/or
vulnerable and willing to endure severe financial hardship, were able to utilise the
services of cosmetic surgeons, the phenomenon of affordable cosmetic surgery
abroad might be seen to be egalitarian. If we recall arguments about cosmetic
surgery ‘normalising perfection’, which may eventually result in an underclass of
cosmetically unenhanced, then it might be argued that cosmetic surgery tourism
provides new hope to those previously unable to afford such surgery.
Yet the counter argument is that by making cosmetic surgery even more readily
available to wider groups of women, we are perpetuating and heightening the
harmful cultural normalisation of enhanced beauty. So while such surgical tourism
might democratise access to this form of enhancement, we would argue that this is
not a positive development. Resisting the inequity of the normalisation of perfection
by making it more accessible will only create more pressure to conform. The only
way is to resist such normalisation is arguably to restrict such surgery, to deter
surgeons from bad practice and to reduce the demand for it, but is this is possible?
Regulating (Harmful) Cosmetic Surgery in a Global Context
How do we deal with the harms (both physical and cultural) that stem from domestic
and foreign surgery? From the available evidence we might predict that tightening
regulation, or even criminalising certain cosmetic surgery in the UK, would fuel
demand for surgery abroad. The motivating factor for such travel is currently
financial but it is probably accurate to forecast that if stricter regulation meant that
accessing surgery in the UK became more difficult, ease of access to certain foreign
services would become important. How much harm will stem from this depends
upon the nature and scope of regulatory approaches in other jurisdictions. Many
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countries have a regulatory approach that is equal, or superior, to that of the UK.
France, as we have mentioned, now takes a much more precautionary approach than
the UK, with recent legislation which has tightened up practices in order to
safeguard patients [20]. Yet the most popular venues seem to have a more relaxed
approach to regulation. With respect to Europe wide regulation, the European
Committee for Standardisation (CEN) has very recently produced a European
Standard for Aesthetic surgery services within the 33 member countries.10 Speaking
about the new standard, the chair of the group, Dr Johann Umschaden, an Austrian
specialist surgeon stated:
Even if there are specific regulations in some EU Members States on aesthetic
surgery, some of them are lacking in terms of hygienic, technical issues, or
they don’t include a risk analysis. Recent reports on incidents in the context of
aesthetic surgery emphasize the importance of this comprehensive European
Standard which was developed through an open, inclusive, multi disciplinary
and evidence based process [6].
The standard is, of course, voluntary and so does not compel providers to improve
the quality and safety of their services. Prospective consumers can, however, select
only those providers who sign up to the standard, thus improving their chances of
having a safer experience. We may therefore view the CEN Standard as a step in the
right direction towards a more uniform and better regulatory approach, at least in
Europe, though only time will tell us whether the anticipated improvements occur.
However, CEN Standard does not cover all of the countries that are significant
cosmetic surgery destinations for UK women seeking surgery and so perhaps a
global regulatory response is necessary. Because the problems of normalisation and
the unwelcome societal implications reach far beyond Europe, it seems that global
regulation would serve an important function, however, there are obvious
difficulties in constructing any global response. First, there are wide differences
in attitudes towards acceptable levels of risk and gaps in commercial medical
services. In addition global regulation will compete against drives to encourage and
open new markets and the free flow of services. Moreover, in such a global market,
cost will ultimately be the most significant driver and as we know, regulatory
measures, however soft, are invariably expensive which would render them
unattractive to many jurisdictions.
In view of the clear evidence of the risks in cosmetic surgery and regulatory
inadequacy both domestically and globally, are we asking too much of the law in this
context? We see merit in Sharon Cowan’s argument that we perhaps need to take a
break from the legal in order to transform the social, or at least use the social and the
legal together, to address the harms that cosmetic surgery arguably perpetuates [7].
Thus, rather than focusing solely on using a regulatory response to discourage harmful
surgery, we should also be considering how we might challenge the culture that
positions women in relation to the normalised representations of beauty. But the legal
is not redundant. Tighter regulation in theUK, including using the criminal law against
10 See http://standards.cen.eu/dyn/www/f?p=204:110:0::::FSP_PROJECT:36242&cs=176A1D8411
18B7605821C83828D8A19A8. Accessed 10 August 2015.
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surgeons who cause harm when they proceed with risky surgeries, will not prevent
people from seeking services abroad. However a domestic response would hopefully
send out symbolic message that such surgery is potentially dangerous and should
therefore be treatedwith great caution.Here the legal and social couldwork together in
the way Cowan describes. While the impact of the law may not be direct or quick to
change social perceptions of cosmetic surgery, in the long run, knowing that cosmetic
surgery in the UK is restrictively regulated may alert people to the dangers of the
practice they are about to undertake. In light of the constraints on applying effective
legislation on a global level, this domestic response could be to the best hope foring the
harms of the global cosmetic surgery industry. Our approach would prioritise changes
in domestic regulation but accepts that, as Riles argues, we must resist relying solely
on law tomould the social world around us andmust use it as in combinationwith other
strategies of transformation [23].
Conclusion
We have considered the complex and sometimes conflicting evidence regarding
domestic cosmetic surgery and the risks of seeking services abroad. Our research
suggests that the very real physical and cultural risks of cosmetic surgery, wherever it
is performed, coupled with the normalisation of the surgically enhanced female,
means that stricter control via regulation is desirable. A global regulatory response is
unlikely, especially for the UK during a time in which (post Brexit) we are retreating
from cross border regulation. Thus we should pin our hopes on domestic regulation.
Considering the precise forms of any such stricter regulation is beyond the scope of this
paper, yet as a starting point we have suggested that the French approach, which
regulates advertising, marketing, informed consent and which necessitates a cooling
off period, would better safeguard consumers. Additionally, the assumption that all
cosmetic surgery ismedically justified—and so beyond the reach of the criminal law—
simply because qualified doctors are performing it, should be reviewed in order to
adopt a more nuanced approach. This, we have argued, should include recourse to the
criminal law when patients are harmed in certain circumstances.
Tightening regulation may not prevent people seeking such treatment elsewhere
but by changing the law and thus sending a clear message about the harms of such
surgery, we suggest that it would alert at least some potential consumers to the
dangers and make some people reconsider the wisdom of cosmetic surgery.
Questioning the medical ethics of performing harmful, highly invasive surgery for
purely aesthetic purposes and subsequently tightening the regulatory approach
would deny cosmetic surgery the credibility and legitimation it currently receives.
While such changes in domestic regulation may drive an increase in people seeking
out foreign providers it may also have certain other indirect effects that would deter
such surgery and thwart normalisation by delegitimising it. This would, we argue,
make women think twice about seeking cosmetic surgery at home or abroad.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
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made.
References
1. Baker, D. (2014). Should unnecessary harmful nontherapeutic cosmetic surgery be criminalised. New
Criminal Law Review, 17(4), 587–630.
2. Bell, D., Holliday, R., Ormond, M., & Mainil, T. (2015). Transnational healthcare, cross-border
perspectives. Social Science and Medicine, 124, 284–289.
3. Bennett, T. (2015). Cuts and criminality: Bodily alteration in legal discourse. Surrey: Ashgate.
4. Bordo, S. (1989). The body and the reproduction of femininity. In A. Jagger & S. Bordo (Eds.),
Gender/body/knowledge: Feminist reconstructions of being and knowing. New Brunswick: Rutgers
University Press.
5. British Association of Asethetic Plastic Surgeons Annual Audit (BAAPS). (2013). http://baaps.org.
uk/about-us/press-releases/1833-britain-sucks.
6. CEN Press release. (2015). ftp://cencenelec.eu/CEN/News/PR/PR-CEN-20150120.pdf. Accessed 10
Aug 2015.
7. Cowan, S. (2015). Sex/gender equality: Taking a break from the legal to transform the social. In D.
Cowan & D. Wincott (Eds.), Exploring the ‘Legal’ in socio-legal studies (pp. 246–270). Basingstoke:
Palgrave MacMillan.
8. Elliot, A. (2008).Making the cut: How cosmetic surgery is transforming our lives. London: Reaktion.
9. Fogli, S. (2009). France sets standards for practice of cosmetic surgery. Clinical Risk, 15(6), 224.
10. Gallager, J. (2014). Plastic surgery ‘‘booming’’ in the UK (BBC News). http://www.bbc.co.uk/news/
health-25986840. Accessed 20 Dec 2015.
11. Gimlin, D. (2014). National healthcare rhetoric beyond the nation: The materiality of narrative in
cosmetic surgery tourism. Tourist Studies, 14(3), 302–318.
12. Griffiths, D., & Mullock, A. (2015). The medical exception and cosmetic surgery: Culpable doctors
and harmful enhancement? In S. Fovargue & A. Mullock (Eds.), The legitimacy of medical treat-
ment: What role for the medical exception?. London: Routledge.
13. Hanefeld, J., Horsfall, D., Lunt, N., Smith, R. (2013) Medical tourism: A cost or benefit to the NHS?
PLoS ONE, 8(10), E70406.
14. Holliday, R., Bell, D., Cheung, O., Jones, M., & Probyn, E. (2015). Brief encounters: Assembling
cosmetic surgery tourism. Social Science and Medicine, 124, 298–304.
15. Jeevan, D., & Armstrong, A. (2008). Cosmetic tourism and the burden on the NHS’. Journal of
Plastic, Reconstructive & Aesthetic Surgery, 61, 1423–1424.
16. Kazarian, M., Griffiths, D., & Brazier, M. (2011). Criminal responsibility for medical malpractice in
France. Journal of Professional Negligence, 27(4), 188–199.
17. Keogh Report: Review Committee, Review of the Regulation of Cosmetic Interventions: Final
Report. (Department of Health, 2013).
18. Kmietowicz, A. (2014). Surgeons condemn UK’s lack of action on regulating cosmetic treatments.
BMJ, 348, g1577.
19. Latham, M. (2008). Medical law review, 16(3), 437–457.
20. Latham, M. (2014). If it ain’t broke, don’t fix it?’: Scandals, ‘Risk’’, and cosmetic surgery regulation
in the UK and France. Medical Law Review, 22(2), 384–408.
21. McHale, J. (2015). Children, cosmetic surgery and perfectionism: A case for legal regulation. In P.
R. Ferguson & G. I. Laurie (Eds.), Inspiring a Medico-Legal Revolution: Essays in honour of Sheila
McClean (pp. 189–200). Surrey: Ashgate.
22. Pitts-Taylor, V. (2009). Becoming-being a cosmetic surgery patient: Semantic instability and the
intersubjective self. Studies in Gender and Sexuality, 10(3), 122.
23. Riles, A. (2005). A new agenda for the cultural study of law: Taking on the technicalities. Buffolo
Law Review, 53, 973.
24. Sanchez Taylor, J. (2012). Fake breasts and power: Gender, class and cosmetic surgery. Women’s
Studies International Forum, 35, 458.
25. Swarbrooke, J., & Horner, S. (2007). Consumer behaviour in tourism. London: Routledge.
26. Weiss, G. (1998). Body images: embodiment as intercorporeality. London: Routledge.
Health Care Anal
123
